Teens seeking addiction care unlikely to be offered standard medication
Adolescents who seek treatment for opioid addiction at an inpatient facility are more likely to…
Category: Medicine
STAT+: Moving past regulatory obstacles, Protagonist Therapeutics looks to pivotal trial for its rare blood disorder therapy
FRANKFURT, Germany — Protagonist Therapeutics has run into some speed bumps as it’s developed its…
STAT+: Pharmalittle: Exec nominated to Biogen board is mother of outgoing director’s child; telehealth company pauses Wegovy ads amid shortages
Top of the morning to you, and a fine one it is. Sunny skies and…
STAT+: Biotech executive nominated to Biogen board is mother of director’s child, records show
Biogen, a biotech giant plagued by years of boardroom strife, said late Monday that the…
Suicide hotlines promise anonymity. Dozens of their websites send sensitive data to Facebook
This article was co-published with The Markup, a nonprofit newsroom that investigates how powerful institutions…
Hospitals are testing AI to communicate with patients. They still don’t know how to talk to them about it
Health systems across the country are exploring blending artificial intelligence into their communication with patients,…
STAT+: Transplant patients say new Medicare guidance puts their donated organs at risk
Margaret Gamble was supposed to receive a blood test in the mail in May. It’s…
Opinion: How predominantly white hospital leadership teams hurt care for people of color
Last year, my father, a Jamaican immigrant with Medicaid insurance, passed away from a heart…
Ro pauses advertising of weight loss drug Wegovy amid shortages
Telehealth company Ro has paused advertising of the obesity drug Wegovy as the drug suffers…
Obesity impairs brain responses to nutrients, even after weight loss, study finds
Brain responses to nutrients in the gut are impaired in people with obesity, and that…
STAT+: Pharmalittle: U.S. Chamber sues over Medicare price negotiations; FDA seeks new supplier for scarce cancer drug
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Fed up with exorbitant health costs, employers and workers are taking insurers to court
Companies, unions, and workers are at a breaking point over how much they pay for…
STAT+: The inside story of how data integrity issues roiled a biotech seen as ‘Moderna 2.0’
In February 2022, Diego Miralles, then-CEO of a buzzy new biotech called Laronde, gathered his…
Opinion: The court system is not ready for child custody disputes over gender-affirming care
The fight over how doctors should treat transgender children is threatening to tear apart an…
.jpg)
STAT+: Novartis to buy Chinook Therapeutics, developer of kidney disease therapies, in $3.2 billion deal
LONDON — Novartis said on Monday it would purchase Chinook Therapeutics for $3.2 billion upfront,…
STAT+: Francis deSouza’s tenure at Illumina is a lesson in how not to handle CEO succession
The sudden resignation of Francis deSouza as the CEO of Illumina Sunday represents anything but…
Following board fight, Francis deSouza resigns as Illumina CEO
Just two weeks after surviving an activist investor’s attempt to oust him from Illumina’s board,…
STAT+: Kura Oncology highlights leukemia remission data as it enrolls larger trial
FRANKFURT — A genetically targeted cancer drug from Kura Oncology has helped put more patients’…
STAT+: Chamber of Commerce tries new legal arguments to challenge Medicare drug-price negotiation
WASHINGTON — The U.S. Chamber of Commerce sued the federal government over its new Medicare drug-price…
Top health officials call for more research to support fentanyl test strips
The government’s top addiction scientists and key public health officials are calling for more research…
.jpg)
STAT+: FDA panel unanimously endorses Eisai’s Alzheimer’s drug
Expert advisers to the Food and Drug Administration on Friday voted unanimously in favor of expanding…
STAT+: Drug companies and pharmacies reach $17.3 billion settlement over opioid crisis
Two large drugmakers and two of the biggest pharmacy chains finalized a $17.3 billion deal…
FDA’s letter to medical device maker iRhythm is a warning for the industry
Heart monitoring company iRhythm is in hot water with the Food and Drug Administration, which…
STAT+: ‘Stung’ by Pear’s bankruptcy, a state Medicaid program pauses on digital therapeutics
WASHINGTON — After getting burned by the high-profile implosion of a digital health company, a senior…
Opinion: Why we created a chatbot to help people at risk for eating disorders
In May, a National Public Radio story asked, “Can a chatbot help people with eating…
STAT Virtual Event: Decoding Clinical Trials: How to Spot and Avoid Clinical Trial Risk
Editor’s Note: A livestream of the event will be embedded below at 1 p.m. ET…
STAT+: Trailing other sickle cell drug makers, Editas still sees opportunity for its CRISPR therapy
FRANKFURT — Even as other cutting-edge genetic therapies for sickle cell disease move closer to…
STAT+: Pharmalittle: FDA panel to review Alzheimer’s treatment; FDA advisers back approval of RSV drug for children
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Updated data show long-term benefits of CRISPR treatment for sickle cell, beta thalassemia
FRANKFURT — Updated results released Friday highlighted the lasting benefits of a CRISPR-based medicine for…
STAT+: Tracking the FDA advisory panel on Eisai and Biogen’s treatment for Alzheimer’s disease
The Food and Drug Administration is convening a meeting of outside experts on Friday to…
Opinion: Your health insurance may not be as good your state requires — and it’s perfectly legal
In 2017, the Massachusetts state Legislature passed a law to ensure ease of access to…
How a now-retracted study got published in the first place, leading to a $3.8 million NIH grant
The scientific paper inspired international headlines with its bold claim that the combination of brain…
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
A Food and Drug Administration advisory committee voted overwhelmingly on Thursday to recommend approval of…
Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA
Are drug prices protected by the Constitution? Will Medicare embrace Alzheimer’s disease treatments? And should…
STAT+: Top Senate Republican signals interest in site-neutral reform for hospitals
WASHINGTON — A top Senate Republican signaled his interest in pursuing hospital payment reform to…
STAT+: Study finds supplements of amino acid taurine slow aging in mice and monkeys
The first clue was blind cats. About 50 years ago, K.C. Hayes, a professor of…
AI insight at BIO, Google and Mayo Clinic’s latest effort, & $13 million for health workforce tech
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: If AI invents a new medicine, who gets the patent?
Pharmaceutical and biotech companies are increasingly using artificial intelligence to discover and make drugs and…
STAT+: Pharmalittle: FDA commish calls U.S. drug prices ‘too high’; FDA staff says Eisai and Biogen’s Alzheimer’s drug has benefits
Rise and shine, everyone, another busy day is on the way, although the smoky covering…
BMI is starting to plateau in rich Western countries. That doesn’t mean obesity is solved
This is part of a series about new obesity drugs that are transforming patients’ lives,…
Opinion: Why brain decoding is not mind reading — and why that matters
Recently, my colleagues and I published a study on decoding language from brain recordings made…
STAT+: After gene therapy deaths, Astellas brings in potentially safer treatment for muscle disorder
Astellas Pharma said Thursday it will license and develop a new gene therapy for a…
The Canada wildfires are exposing the harmful effects — and health inequities — of air pollution
Wildfires blazing in and around Quebec are creating hazardous health conditions throughout North America. Over…
Reanimated hearts donated after death work just as well for transplants, study finds
A new method of heart transplantation that uses machines to reanimate donor hearts from people…
STAT+: Sen. Cassidy wants to put a stop to FDA delays in drug review process
WASHINGTON – Sen. Bill Cassidy (R-La.) is looking into ways to speed up the Food…
STAT+: Democrats blast Biden administration over Alzheimer’s drug plans
WASHINGTON — Ahead of a major Food and Drug Administration meeting on a new Alzheimer’s…
How the public health lessons of Covid can help Americans protect themselves from wildfire smoke
An unusually early and ferocious outbreak of forest fires across Canada has sent unprecedented amounts…
CDC comes under fire for inadequate information about its Covid response
WASHINGTON – Republicans aren’t impressed with the Centers for Disease Control and Prevention’s reorganization plan,…
STAT+: ‘We don’t agree’ on drug pricing policy, FDA chief tells biotech leaders
BOSTON — The drug industry has spent the past year speaking against new mechanisms that…
STAT+: After missing vaccine glory in pandemic, GSK looks to dominate other diseases
BOSTON — GSK has been developing vaccines under one corporate guise or another for 140…